1. Home
  2. TALK vs EVO Comparison

TALK vs EVO Comparison

Compare TALK & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talkspace Inc.

TALK

Talkspace Inc.

HOLD

Current Price

$5.17

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.12

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALK
EVO
Founded
2012
1993
Country
United States
Germany
Employees
521
4553
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
788.5M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TALK
EVO
Price
$5.17
$3.12
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$6.42
$7.00
AVG Volume (30 Days)
5.5M
91.3K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.02
$1.29
Revenue Next Year
$21.24
$11.31
P/E Ratio
$155.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$2.31
52 Week High
$5.20
$4.80

Technical Indicators

Market Signals
Indicator
TALK
EVO
Relative Strength Index (RSI) 64.39 66.03
Support Level $4.59 $2.87
Resistance Level $5.19 $3.78
Average True Range (ATR) 0.02 0.08
MACD -0.03 0.09
Stochastic Oscillator 64.29 97.37

Price Performance

Historical Comparison
TALK
EVO

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: